EquityZen Growth Technology Fund LLC - Series 1728
Raised
$100K
Investors
3
Min Invest
$10,184
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1728 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Philip Haslett on August 8, 2023. The entity raised $100K from 3 investors under Rule 506(b) and 3(c)(1) exemptions, with a $10K minimum investment. This is part of EquityZen's platform, which has filed 150+ related EDGAR entities focused on private equity access.
This filing represents a typical small-cap SPV structure within the private equity category, using the standard 506(b)/3(c)(1) exemption combination for private placements. The $10K minimum investment is relatively accessible compared to traditional private equity funds, consistent with EquityZen's model of democratizing access to pre-IPO company shares through series-specific investment vehicles.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
